Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Self-expanding stents improve positioning in primary angioplasty

Original title: Self-Expanding Versus Balloon-Expandable Stents in Acute Myocardial Infarction: Results From the APPOSITION II Study Reference: Robert-Jan van Geuns et al. J Am Coll Cardiol Intv 2012;5:1209–19

Acute myocardial infarction is associated with vasoconstriction and thrombus occlusion. Resolution of these two points during the first hours after primary angioplasty can lead to poor extension and poor positioning of the stent implanted with the probable risk of thrombosis and restenosis. 

On the other hand, aggressive implantation could cause distal embolization. This study tested the hypothesis that self-expanding stents are more effective than balloon-expandable stents to reduce poor positioning after primary angioplasty. We randomized 80 patients with ST elevation acute myocardial infarction (STEMI) who were receiving primary angioplasty with a self-expandable stent (STENTYS, Paris, France) or a balloon-expandable stent (Vision, Abbott Vascular, Santa Clara, California, or Driver, Medtronic, Minneapolis, Minnesota). 

The primary endpoint was the proportion of the struts poor positioning after 3 days of implantation using optical coherence tomography (OCT). The secondary endpoint was major cardiac events such as cardiac death, recurrent infarction or emergency bypass surgery. After 3 days of implantation, the self-expanding stents had a lower percentage of poor strut positioning compared with balloon-expandable (0.58% versus 5.46%, respectively, P <0.001). The major cardiac events at 6 months were not significantly different between groups.

Conclusion 

Self-expanding stents had a lower incidence of poor strut positioning using OCT than balloon-expandable stents after primary angioplasty.

Editorial Comment:

This study lacks sufficient power to show the clinical differences between the two types of stent, however it does show the feasibility and safety of self-expanding stents that have already been tested at bifurcations. A particularly striking feature is the lack of data on the degree of TIMI 3 and Blush post implant. 

Courtesy of Dr. Gustavo Hidalgo.
Fellowship of Interventional Cardiology.
Fundación Favaloro.

Dr. Gustavo Hidalgo para SOLACI.ORG

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

GLUCO-TAVI | Can Glucocorticoids Reduce the Need for Permanent Pacemaker Implantation After TAVI?

Despite the expansion of transcatheter aortic valve implantation (TAVI) indications, cardiac conduction disturbances (CCD) and the need for permanent pacemaker implantation (PPI) remain the...

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...